MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Mizuho

Mizuho started coverage on shares of MannKind (NASDAQ:MNKD – Free Report) in a report issued on Thursday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $12.00 price target on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on the stock. StockNews.com raised shares of MannKind from a […]